Filgrastim (Blausiegel biosimilar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Filgrastim (Blausiegel biosimilar), covering 2018-06-20 to 2018-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A. [Phase 1]